Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Bristol-Myers Squibb: Buy The Weakness
06:03am, Monday, 04'th Aug 2025
Bristol-Myers Squibb faces political pressure on U.S. drug prices, but I see the risk as manageable given its strong fundamentals. The company's growth portfolio now exceeds half of revenue, offsettin
Bristol-Myers Squibb: Declines Have Gone Too Far
10:42am, Saturday, 02'nd Aug 2025
Bristol-Myers Squibb's sales are stabilizing, with Q2 net sales up 1% YoY and growth portfolio drugs like Camzyos and Breyanzi showing strong momentum. Despite margin compression and profitability con
Bristol Myers (BMY) Q2 EPS Jumps 36%
11:23pm, Friday, 01'st Aug 2025
Bristol Myers (BMY) Q2 EPS Jumps 36%
Bristol-Myers Squibb: No Respect For Blowout Earnings - Buy The Richer Dividend Yields
01:42pm, Friday, 01'st Aug 2025
BMY's double-beat FQ2'25 performance and raised FY2025 guidance have been met with much skepticism, as observed in the steep pullback post earnings. This is despite the Growth Portfolio comprising ove
Bristol-Myers Q2 Earnings Review: Solid Quarter, But Incoming CMO Must Fix Pipeline
01:25pm, Friday, 01'st Aug 2025
Bristol-Myers Squibb Company beat Q2 2025 revenue expectations and raised full-year guidance, but EPS guidance was lowered and shares remain under pressure. The company's growth portfolio is expanding
Bristol-Myers Squibb: Growth Is Taking Its Own Time (Rating Downgrade)
01:14pm, Friday, 01'st Aug 2025
Bristol-Myers Squibb's Q2 2025 results were a mixed bag, with revenues showing signs of recovery while earnings saw a pullback. A reduction in earnings guidance on IPRD charges was another disappointm
Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.
Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb
08:31am, Friday, 01'st Aug 2025
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of President Trump ordering pharma companies to lower U.S. drug prices in the next 60 days, the move to tiered pricing glo
President Trump demands drugmakers slash prices within 60 days
06:54am, Friday, 01'st Aug 2025
CNBC's Joe Kernen reports on the latest news.
Bristol-Myers Squibb Company (BMY) Q2 2025 Earnings Call Transcript
04:40pm, Thursday, 31'st Jul 2025
Bristol-Myers Squibb Company (NYSE:BMY ) Q2 2025 Earnings Conference Call July 31, 2025 8:00 AM ET Company Participants Adam Lenkowsky - Executive VP & Chief Commercialization Officer Christopher S. B
Trump pressures 17 pharma CEOs to cut US drug prices
02:28pm, Thursday, 31'st Jul 2025
U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, urging immediate action to lower the cost of prescription drugs for Americans, the White House sa
Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
01:48pm, Thursday, 31'st Jul 2025
President Donald Trump said he asked major pharmaceutical companies to take steps to cut U.S. drug prices within the next 60 days. It comes after Trump in May signed an executive order reviving a cont
Bristol Myers Beats on Q2 Earnings and Sales, Raises '25 Sales View
12:46pm, Thursday, 31'st Jul 2025
BMY's Q2 EPS and revenues beat estimates, powered by strong Growth portfolio sales and a lesser than expected decline in Legacy portfolio sales.
PCE Comes in Warmer Than Expected
12:11pm, Thursday, 31'st Jul 2025
PCE Comes in Warmer Than Expected.
Economy Heating Up on PCE for June
11:46am, Thursday, 31'st Jul 2025
Pre-market and bond yield numbers appear to be in reaction to this morning's economic posts.
